SCHEMBL17394990

SCHEMBL17394990

CSc1ncc(OCCO)cn1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.49
▸ THRB P10828 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.42
▸ RECQL P46063 1/20 0.42
▸ NR1I2 O75469 1/20 0.39
▸ CYP3A4 P08684 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ LMNA P02545 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ LOX P28300 1/20 0.33
▸ AOC3 Q16853 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ F2RL3 Q96RI0 1/20 0.32
▸ MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19503414 0.77 ALDH1A1 (0.46) KMT2ATHRBALDH1A1RECQLNR1I2
SCHEMBL34466788 0.72 ALDH1A1 (0.46) ALDH1A1RECQLNR1I2CYP3A4SMN1; SMN2
SCHEMBL17394947 0.72 DUT (0.34) —
SCHEMBL8354332 0.72 FGFR4 (0.38) KMT2AALDH1A1CYP3A4SMN1; SMN2LMNA
SCHEMBL28944776 0.71 ALDH1A1 (0.41) KMT2ATHRBALDH1A1LMNAMAPT
SCHEMBL17395038 0.71 ACACB (0.30) —
SCHEMBL11149320 0.71 MEN1 (0.41) KMT2AALDH1A1RECQLSMN1; SMN2LMNA
SCHEMBL4322475 0.70 ALDH1A1 (0.48) ALDH1A1RECQLNR1I2CYP3A4SMN1; SMN2
SCHEMBL485902 0.70 LMNA (0.37) KMT2ATHRBRECQLLMNAMAPT
SCHEMBL5231704 0.69 ALDH1A1 (0.54) ALDH1A1RECQLNR1I2CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016001266-A1 FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2016-01-07 — — WO disclosed
Send feedback